Ads by Google

Prostate Cancer Treatment and Symptoms

Genaera Discontinues LOMUCIN In Cystic Fibrosis And Squalamine In Prostate Cancer Studies

Genaera Corporation and Cystic Fibrosis Foundation Therapeutics have agreed for reasons of futility to discontinue the Phase 2 study of LOMUCIN for the treatment of cystic fibrosis (CF).

Satraplatin - Prednisone Combination For Treatment Of Patients With Metastatic Hormone-Refractory Prostate Cancer

Pharmion submitted marketing authorization application Satraplatin in combination with prednisone for the treatment of patients with metastatic hormone-refractory prostate cancer who have failed prior chemotherapy.

Prostate cancer treatment options: Info about new prostate treatments

For many men with early-stage prostate cancer, sorting out the treatment options can be overwhelming. The most important thing to do is to take your time and make sure you explore all prostate cancer treatment choices thoroughly.

Age-Specific PSA Cut-Offs Avoid Unnecessary Prostate Biopsies in Older Men

The introduction of age-specific cut-offs for prostate-specific antigen (PSA) levels used in prostate cancer screening will reduce the number of unnecessary prostate biopsies in older men who naturally have higher levels of PSA than younger men.

Pages